Jon M. Davison, MD
Assistant Professor of Pathology


Dr. Davison is a member of the Division of Anatomic Pathology. He is also a member of the Gastrointestinal Pathology Center of Excellence.

Office Location:
UPMC Presbyterian, Suite A610.1
200 Lothrop Street
Pittsburgh, PA 15213
Contact Information:
Office Telephone: 412-647-6125
Fax: 412-647-6251
Email: davisonjm@upmc.edu

Education

  • BA - University of Notre Dame, 1990
  • MD - Pritzker School of Medicine, 2002

Clinical Expertise

Gastrointestinal pathology, including pathology of the pancreas. I have a special interest in Barrett’s esophagus and esophageal neoplasia.

Research Interests

My primary research interest is the clinical, pathologic and molecular determinants of the behavior and outcomes of esophageal carcinoma and Barrett’s esophagus.

Specialties

Anatomic Pathology and Gastrointestinal Pathology

Selected Publications

View Dr. Davison's publications on PubMed

Radu OM, Foxwell T, Cieply K, Navina S, Dacic S, Nason KS, Davison JM. HER2 Amplification in Gastro-Esophageal Adenocarcinoma: Correlation of Two Antibodies Utilizing Gastric Cancer Scoring Criteria, H Score and Digital Image Analysis with Fluorescence in Situ Hybridization. American Journal of Clinical Pathology (2012, in press).

Goodell PP, Krasinskas AM, Davison JM, Hartman DJ. Comparison of methods for proliferative index analysis for grading pancreatic well differentiated neuroendocrine tumors. American Journal of Clinical Pathology (2012, in press).

Holinga J, Khalid A, Fasanella K, Sanders M, Davison J, McGrath K. Metastatic risk of diminutive rectal carcinoid tumors: a need for surveillance rectal ultrasound? Gastrointestinal Endoscopy. 2012 Jan 25 [epub ahead of print].

Hartman DJ*, Davison JM*, Foxwell TJ, Nikiforova MN, Chiosea SI. Mutant allele specific imbalance modulates prognostic impact of KRAS mutations in colorectal adenocarcinoma and is associated with worse overall survival. International Journal of Cancer. 2012 Jan 30. doi: 10.1002/ijc.27461. (* co-first authors)

Woodard AH, Yu J, Dabbs DJ, Beriwal S, Florea AV, Elishaev E, Davison JM, Krasinskas AM, Bhargava R. NY-BR-1 and PAX8 immunoreactivity in breast, gynecologic tract, and other CK7+ carcinomas: potential use for determining site of origin. American Journal of Clinical Pathology. 2011 Sep;136(3):428-35.

Thakur PC, Stuckenholz C, Rivera MR, Davison JM, Yao JK, Amsterdam A, Sadler KC, Bahary N. Lack of de novo phosphatidylinositol synthesis leads to endoplasmic reticulum stress and hepatic steatosis in cdipt-deficient zebrafish. Hepatology. 2011 Aug;54(2):452-62.

Badylak SF., Hoppo T, Nieponice A, Gilbert TW, Davison JM and Jobe BA. Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold. Tissue Engineering Part A. 2011 Jun;17(11-12):1643-50.

Kissloff B, McGrath KM and Davison JM. Esophageal Hyperkeratosis in a healthy adult. Clinical Gastroenterology and Hepatology 2011 Jun;9(6):A20.

Mavanur AA, Parimi V, O'Malley M, Nikiforova M, Bartlett DL, Davison JM. Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinoma. International Journal of Experimental Pathology 2010 Aug;91(4):357-67. Epub 2010 Jun 25.

Voong KR, Davison JM, Pawlik TM, Uy MO, Hsu CC, Winter J, Hruban RH, Laheru D, Rudra S, Swartz MJ, Nathan H, Edil BH, Schulick R, Cameron JL, Wolfgang CL, Herman JM (2010), Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients. Human Pathology 41(1):113-122.